A Phase III, Randomized, Open Label, Multicenter Study Evaluating The Efficacy And Safety Of Cevostamab In Combination With Pomalidomide And Dexamethasone Versus Standard Of Care In Patients With Multiple Myeloma Who Have Received One To Three Prior Lines Of Therapy (CEVOLUTION)

Principal Investigator

Dr Karthik Ramasamy

Contact us

Email: Latephasehaematology@ouh.nhs.uk

IRAS number

1013612